Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803-827. Revista portuguesa de pneumologia [Rev Port Pneumol] Journal article | | Title | Araújo A, et al. An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer Rev Port Pneumol 2008; 14(6):803-827. | | Author(s) | Bartminski W | | Source | Rev Port Pneumol 2009 May-Jun; 15(3):555-9; author reply 560-6. | | Language | eng | | Pub Type(s) | Comment
Letter
| | PubMed ID | 19526635 |
|
|
| |
Advertise on this site.
| | |
|
